FDA Inspection 789660 — McLaren Health Care Corporate Institutional Review Board
The FDA completed an inspection of McLaren Health Care Corporate Institutional Review Board on July 3, 2012 in Auburn Hills, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 3, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Auburn Hills, MI (United States)
Additional Details
IRB